Global equitable access to Covid-19 vaccines estimated to generate economic benefits of at least $153 billion in 2020–21, and $466 billion by 2025, in 10 major economies, according to a new report by the Eurasia Group , global political risk research and consulting firm. As world leaders gather virtually at the Special Session of the General Assembly in response to the Covid-19 pandemic, new data published today finds that Leaving ...